In a report published on Tuesday, Morgan Stanley analyst David Friedman downgraded XenoPort XNPT from Equal-weight to Underweight and lowered the price target on the company from $3 to $2 on the recent Ph 3 AP failure.
In the report, Morgan Stanley stated, "We are downgrading to UW post the recent Ph 3 AP failure. We do not believe Horizant sales will accelerate, and view ‘829 as a) early stage, b) likely a long time from the market, and c) not clearly differentiated in a competitive MS market."
XenoPort closed at $5.51 on Monday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in